Vertex Pharmaceuticals Inc (VRTX) Insider Trading
- $14,887,810.00
- $1,037,179,923.19
- March 13, 2026
- Joshua S Boger
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| Nov. 25, 2013 | Director | 1,400 | $66.89 | Sell | $93,646.00 | |
| Nov. 20, 2013 | Director | 8,300 | $65.28 | Sell | $541,824.00 | |
| Nov. 19, 2013 | Director | 1,400 | $62.31 | Sell | $87,234.00 | |
| Nov. 5, 2013 | Director | 1,400 | $65.64 | Sell | $91,896.00 | |
| Oct. 29, 2013 | SVP | 1,688 | $75.04 | Sell | $126,667.52 | |
| Oct. 29, 2013 | Director | 1,400 | $75.42 | Sell | $105,588.00 | |
| Oct. 24, 2013 | Director | 8,300 | $77.06 | Sell | $639,598.00 | |
| Oct. 23, 2013 | Director | 1,400 | $76.77 | Sell | $107,478.00 | |
| Oct. 16, 2013 | Director | 1,400 | $75.41 | Sell | $105,574.00 | |
| Oct. 15, 2013 | EVP | 7,500 | $73.25 | Sell | $549,375.00 | |
| Oct. 14, 2013 | SVP | 1,593 | $71.87 | Sell | $114,488.91 | |
| Oct. 9, 2013 | Director | 1,400 | $72.35 | Sell | $101,290.00 | |
| Sept. 25, 2013 | Director | 1,400 | $74.72 | Sell | $104,608.00 | |
| Sept. 18, 2013 | Director | 1,400 | $77.43 | Sell | $108,402.00 | |
| Sept. 16, 2013 | EVP | 7,500 | $77.22 | Sell | $579,150.00 | |
| Sept. 11, 2013 | Director | 1,400 | $79.61 | Sell | $111,454.00 | |
| Sept. 4, 2013 | Director | 1,400 | $75.45 | Sell | $105,630.00 | |
| Aug. 29, 2013 | Director | 8,300 | $77.19 | Sell | $640,677.00 | |
| Aug. 28, 2013 | Director | 1,400 | $76.24 | Sell | $106,736.00 | |
| Aug. 21, 2013 | Director | 1,400 | $76.96 | Sell | $107,744.00 | |
| Aug. 15, 2013 | EVP | 7,500 | $77.41 | Sell | $580,575.00 | |
| Aug. 14, 2013 | Director | 1,400 | $77.18 | Sell | $108,052.00 | |
| Aug. 7, 2013 | Director | 1,400 | $77.84 | Sell | $108,976.00 | |
| Aug. 5, 2013 | SVP | 3,001 | $78.90 | Sell | $236,778.90 | |
| July 31, 2013 | Director | 1,400 | $80.89 | Sell | $113,246.00 | |
| July 29, 2013 | Director | 9,800 | $80.09 | Sell | $784,882.00 | |
| July 25, 2013 | SVP | 1,125 | $86.49 | Sell | $97,301.25 | |
| July 24, 2013 | Director | 8,300 | $85.50 | Sell | $709,650.00 | |
| July 19, 2013 | SVP | 22,250 | $88.69 | Sell | $1,973,352.50 | |
| July 18, 2013 | Director | 1,400 | $86.12 | Sell | $120,568.00 | |
| July 16, 2013 | SVP | 2,063 | $86.25 | Sell | $177,933.75 | |
| July 15, 2013 | SVP | 1,125 | $86.35 | Sell | $97,143.75 | |
| July 15, 2013 | EVP | 7,500 | $86.34 | Sell | $647,550.00 | |
| July 12, 2013 | SVP | 10,678 | $85.00 | Sell | $907,630.00 | |
| July 11, 2013 | Director | 1,400 | $83.83 | Sell | $117,362.00 | |
| July 8, 2013 | EVP | 1,813 | $80.72 | Sell | $146,345.36 | |
| July 8, 2013 | SVP | 28,703 | $80.89 | Sell | $2,321,785.67 | |
| July 5, 2013 | SVP | 4,687 | $81.21 | Sell | $380,631.27 | |
| July 3, 2013 | Director | 1,400 | $80.20 | Sell | $112,280.00 | |
| July 2, 2013 | EVP | 122,300 | $79.80 | Sell | $9,759,540.00 | |
| June 26, 2013 | Director | 1,400 | $78.59 | Sell | $110,026.00 | |
| June 21, 2013 | Director | 8,300 | $75.93 | Sell | $630,219.00 | |
| June 19, 2013 | Director | 1,400 | $79.11 | Sell | $110,754.00 | |
| June 12, 2013 | Director | 1,400 | $81.19 | Sell | $113,666.00 | |
| June 5, 2013 | Director | 1,400 | $77.15 | Sell | $108,010.00 | |
| May 30, 2013 | Director | 1,400 | $82.47 | Sell | $115,458.00 | |
| May 22, 2013 | Director | 1,400 | $79.72 | Sell | $111,608.00 | |
| May 15, 2013 | Director | 1,400 | $79.36 | Sell | $111,104.00 | |
| May 14, 2013 | Director | 60,000 | $81.15 | Sell | $4,869,000.00 | |
| Dec. 26, 2012 | Director | 4,000 | $41.86 | Sell | $167,440.00 |
Insiders are both buying and selling Vertex Pharmaceuticals Inc stock.
The insider traders at Vertex Pharmaceuticals Inc are: Joshua S Boger, Paul M Silva, Stuart A Arbuckle, Amit Sachdev, Jeffrey M Leiden, Michael Parini, David Altshuler, Jeffrey Chodakewitz, Joshua S. Boger, Yuchun Lee, Ourania Tatsis, Reshma Kewalramani, Sangeeta N Bhatia, Ian F Smith, Bruce I Sachs, Bastiano Sanna, Joshua Boger, Peter Mueller, Carmen Bozic, Charles F Wagner Jr, Margaret G Mcglynn, Kristen Ambrose, Elaine Ullian, Bruce Sachs, Stuart A. Arbuckle, Jonathan Biller, Joy Liu, Kenneth L Horton, Megan E Pace, Megan Pace, Jeffrey Leiden, Edward Morrow Atkinson III, Wayne Joseph Riley, Thomas Graney, Mark E Bunnage, Paul Silva, Christiana Stamoulis, Lloyd Carney, Terrence C Kearney, Thomas Connolly, Jeffrey M. Leiden, Kenneth Horton, Paul M. Silva, Ian F. Smith, William D Young, Duncan Mckechnie, and Sangeeta N. Bhatia
The most active insider trader at Vertex Pharmaceuticals Inc is Joshua S Boger with 99 trades.
Jeffrey M Leiden has sold the most Vertex Pharmaceuticals Inc stock with a total value of $395,375,749.22.
Reshma Kewalramani has bought the most Vertex Pharmaceuticals Inc stock with a total value of $17,310,520.00.
The most recent insider trade for Vertex Pharmaceuticals Inc was on March 13, 2026.
The single biggest insider buy for Vertex Pharmaceuticals Inc was from Reshma Kewalramani with a total value of $7,677,010.00 on July 30, 2024.
The single biggest insider sell for Vertex Pharmaceuticals Inc was from Jeffrey M Leiden with a total value of $37,164,389.02 on July 25, 2022.